Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Esketamine with Hip Capsule Block in Elderly THA
NCT05602428Completed
- Start
- Jan 2020
- Primary completion
- May 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, open-label trial of esketamine in total hip arthroplasty (THA) (3 arms). Primary endpoints: Onset time of anesthesia at 5 minutes, Duration of block time at 350 minutes and 7 more. Started Jan 2020; status: completed.
02
Drugs
esketamine
03
Conditions
total hip arthroplasty (THA)
Beyond the preview
Go deeper on NCT05602428.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05602428.